Aspen Aerogels (NYSE:ASPN) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Aspen Aerogels (NYSE:ASPN) to a sell rating in a report published on Saturday.

Other equities analysts have also recently issued research reports about the company. HC Wainwright reissued a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. Barclays dropped their price target on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. Roth Mkm lowered their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Canaccord Genuity Group lowered their price objective on Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a research report on Thursday, January 16th. Finally, Piper Sandler lowered their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $29.11.

Aspen Aerogels Stock Performance

NYSE ASPN opened at $12.03 on Friday. The stock has a 50-day moving average of $12.50 and a 200 day moving average of $18.81. Aspen Aerogels has a twelve month low of $10.67 and a twelve month high of $33.15. The stock has a market capitalization of $986.65 million, a price-to-earnings ratio of 1,203.70 and a beta of 2.14. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. FMR LLC raised its stake in shares of Aspen Aerogels by 23.6% in the third quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock valued at $112,169,000 after acquiring an additional 773,647 shares in the last quarter. Prescott Group Capital Management L.L.C. acquired a new stake in shares of Aspen Aerogels in the fourth quarter valued at $5,126,000. Telemark Asset Management LLC raised its stake in shares of Aspen Aerogels by 26.8% in the fourth quarter. Telemark Asset Management LLC now owns 1,892,424 shares of the construction company’s stock valued at $22,482,000 after acquiring an additional 400,000 shares in the last quarter. Lord Abbett & CO. LLC acquired a new stake in shares of Aspen Aerogels in the third quarter valued at $10,126,000. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Aspen Aerogels by 204.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 509,430 shares of the construction company’s stock valued at $14,106,000 after acquiring an additional 342,253 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.